- Home
- FLUX vs MURA Comparison
FLUX vs MURA Comparison
Compare FLUX & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- MURA
- Stock Information
- Founded
- FLUX N/A
- MURA 2013
- Country
- FLUX United States
- MURA Ireland
- Employees
- FLUX N/A
- MURA N/A
- Industry
- FLUX Industrial Machinery/Components
- MURA
- Sector
- FLUX Miscellaneous
- MURA
- Exchange
- FLUX Nasdaq
- MURA Nasdaq
- Market Cap
- FLUX 38.0M
- MURA 36.0M
- IPO Year
- FLUX N/A
- MURA N/A
- Fundamental
- Price
- FLUX $1.54
- MURA $2.09
- Analyst Decision
- FLUX Strong Buy
- MURA Buy
- Analyst Count
- FLUX 2
- MURA 2
- Target Price
- FLUX $6.00
- MURA $6.00
- AVG Volume (30 Days)
- FLUX 1.0M
- MURA 106.7K
- Earning Date
- FLUX 11-13-2025
- MURA 11-06-2025
- Dividend Yield
- FLUX N/A
- MURA N/A
- EPS Growth
- FLUX N/A
- MURA N/A
- EPS
- FLUX N/A
- MURA N/A
- Revenue
- FLUX $63,484,000.00
- MURA N/A
- Revenue This Year
- FLUX $8.23
- MURA N/A
- Revenue Next Year
- FLUX $24.72
- MURA N/A
- P/E Ratio
- FLUX N/A
- MURA N/A
- Revenue Growth
- FLUX 2.13
- MURA N/A
- 52 Week Low
- FLUX $1.15
- MURA $0.95
- 52 Week High
- FLUX $7.55
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- FLUX 31.57
- MURA 50.82
- Support Level
- FLUX $1.47
- MURA $2.06
- Resistance Level
- FLUX $1.83
- MURA $2.10
- Average True Range (ATR)
- FLUX 0.27
- MURA 0.02
- MACD
- FLUX -0.09
- MURA -0.00
- Stochastic Oscillator
- FLUX 10.77
- MURA 50.00
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.